 HOUSTON, July 09, 2021 GLOBE NEWSWIRE -- Salarius Pharmaceuticals, Inc. Nasdaq: SLRX, a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, announced today that David Arthur, Chief Executive Officer, will present virtually at the 2021 Ladenburg Thalmann Healthcare Conference on Tuesday, July 13, 2021, at 3 p.m., ET. The presentation can be accessed via the conferences virtual platform by registered conference attendees. 